Home › Respiratory Distress Syndrome › North Carolina
Respiratory Distress Syndrome clinical trials in North Carolina
9 studies for Respiratory Distress Syndrome are looking for participants at sites in North Carolina.
Cities in North Carolina
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Durham
- Research Site, Winston-Salem
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05624450JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
- University of North Carolina at Chapel Hill, Chapel Hill
- Durham VA Medical Center, Durham
- Duke Lung Transplant Clinic - Clinic 2F/2G - PPDS, Durham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
- University of North Carolina at Chapel Hill, Chapel Hill
- Durham VA Medical Center, Durham
- Duke Lung Transplant Clinic - Clinic 2F/2G - PPDS, Durham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701682JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
- University of North Carolina at Chapel Hill, Chapel Hill
- Durham VA Medical Center, Durham
- Duke Lung Transplant Clinic - Clinic 2F/2G - PPDS, Durham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701656JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
- University of North Carolina at Chapel Hill, Chapel Hill
- Durham VA Medical Center, Durham
- Duke Lung Transplant Clinic - Clinic 2F/2G - PPDS, Durham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06703073Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
- Duke University Medical Center, Durham
- Atrium Health Wake Forest Baptist, Winston-Salem
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT06066502Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
- Direct Biologics Investigational Site, Durham
- Direct Biologics Investigational Site, Winston-Salem
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Feb 23, 2026 · NCT05354141The APS Phenotyping Study
- Duke University, Durham
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 20, 2026 · NCT06521502Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Wakemed, Raleigh
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.